Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Editorial team
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami strengthens commercial operations with appointment of Will Isom as Vice President of Laboratory Services Sales Alcami, a leading contract development and manufacturing organisation (CDMO), today announced the appointment of biologics industry veteran Will Isom as Vice President of... Codis appoints Steven Facer as Chief Commercial Officer Codis appoints Steven Facer as Chief Commercial Officer Codis appoints Steven Facer as Chief Commercial Officer Codis, a global contract development and manufacturing organisation (CDMO) specialising in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering,... Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa selected as technology partner for Africa’s new continent-wide medicines safety platform Qinecsa will help deliver a continent-wide medicines safety platform connecting safety data across Africa Chiesi appoints David Khougazian as Group chief executive officer Chiesi appoints David Khougazian as Group chief executive officer Chiesi appoints David Khougazian as Group chief executive officer David Khougazian to lead the next phase of innovation-driven growth CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer CordenPharma appoints Dr Jean-Luc Herbeaux as Chief Executive Officer Leadership transition marks the next phase of growth following 12 years of transformation under Dr Michael Quirmbach Gerresheimer names new Chairman of the Supervisory Board Gerresheimer names new Chairman of the Supervisory Board Gerresheimer names new Chairman of the Supervisory Board This year's AGM featured the election of four shareholder representatives to the Supervisory Board, including Sieger as Chairman Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Scenic Biotech appoints renowned neurology drug development leader Dr. Judith Walker as Chief Medical Officer Dr. Walker joins to lead Scenic's transition into clinical development and shape its clinical strategy Hovione appoints Stefan Doboczky as Chief Executive Officer Hovione appoints Stefan Doboczky as Chief Executive Officer Hovione appoints Stefan Doboczky as Chief Executive Officer Chairman of the board of directors Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027 Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Yusen Logistics appoints Gilbert den Bekker as chief commercial officer for Europe Experienced commercial leader joins Yusen Logistics to support sustainable growth and strengthen commercial collaboration across Europe Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience Specialist pharmaceutical experience strengthens Symbiosis’ international growth ambitions Virginie Cavalli appointed Chief Executive Officer of Seppic Virginie Cavalli appointed Chief Executive Officer of Seppic Virginie Cavalli appointed Chief Executive Officer of Seppic Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer, effective September 1, 2026 Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Uwe Röhrhoff steps down as Interim CEO of Gerresheimer AG Wolf Lehmann, CFO, and Achim Schalk, Member of the Management Board, will assume his duties until further notice Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis strengthens commercial team with appointment of Jay Chima Symbiosis appoints Jay Chima as vice president, business development, to support growth and strengthen partnerships across the pharmaceutical and biotechnology sectors Lonza appoints Samanta Cimitan as chief commercial officer Lonza appoints Samanta Cimitan as chief commercial officer Lonza appoints Samanta Cimitan as chief commercial officer Newly created role will strengthen customer engagement, commercial delivery and a harmonised go-to-market approach across One Lonza Piramal Pharma completes acquisition of controlling stake in Yapan Bio Piramal Pharma completes acquisition of controlling stake in Yapan Bio Piramal Pharma completes acquisition of controlling stake in Yapan Bio Acquisition strengthens Piramal’s biologics capabilities and integrated large molecule CDMO offering Anders Fogelberg appointed president and CEO of BICO Group AB Anders Fogelberg appointed president and CEO of BICO Group AB Anders Fogelberg appointed president and CEO of BICO Group AB BICO appoints current Chief Commercial Officer Anders Fogelberg as President and CEO, effective September 1, 2026
  • Previous
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 217
  • Next

Trending Articles

  1. Beckman Coulter Diagnostics appoints Catherine Jennings as president Former Boston Scientific executive to lead strategic and operational priorities at global diagnostics company
  2. Simris appoints ADC specialist as chief medical officer Dr András Strassz joins the Swedish biotechnology company to lead clinical development as it advances its antibody-drug conjugate pipeline
  3. EyeC expands OEM growth with new business development manager Rigel Gallegos will lead the development of EyeC’s OEM and system integrator business
  4. DFE Pharma appoints Peter Rose as new Chief Operating Officer The appointment reinforces DFE Pharma’s commitment to reliable supply, scalable operations and continuous improvement
  5. AlzeCure Pharma announces change of CEO ahead of next phase of development AlzeCure Pharma AB (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer’s disease and pain, announces today that CEO Martin Jönsson is stepping down and is being replaced on an interim basis by the company’s Chief Scientific Officer and co-founder, Dr. Johan Sandin. The Board of Directors will now initiate the recruitment process for a permanent CEO

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK. Terms and Conditions | Privacy